I had a recent correspondence with someone who wanted to discuss the off-label use of Anakinra, an IL1RAP blocker, for her early Dupuytren disease because it had worked so well (off-label) for a problem she had similar to frozen shoulder. It turns out, there are a few small reports of favorable responses to this drug […]
Read more ›
Heads and Hands: Biomarkers Biomarkers are the focus of Dupuytren Research Group research – the International Dupuytren Data Bank. Researchers in many medical specialties are searching for biomarkers, not just to find new treatments, but as a guide to current treatment. Blood test biomarkers are under investigation for better management and eventually prevention of post-concussive […]
Read more ›
The International Dupuytren Data Bank (IDDB) will focus on Dupuytren biomarkers Why are biomarkers important for Dupuytren disease? Dupuytren contracture is an effect, not a cause. Think of fever. Fever is an effect of infection, drug reaction, or something else. Just treating the effect – the fever – doesn’t cure the cause. You have to find […]
Read more ›